Incyte

At a glance

Incyte reported 2025 revenue of $5.14B, up 21.2% from $4.24B in 2024. Over 4 years since 2021 ($2.99B), that is growth of about 14.5% a year. Operating margin was 29.5%, up from 19.6% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 10 insiders reported 0 open-market purchases and 29 sales ($58.3M). All of the sales were made under pre-arranged 10b5-1 trading plans. The largest was a sale of $19.8M by Director Herve Hoppenot on Nov 12, 2025.

Incyte filed 13 current reports (Form 8-K) in the last 12 months, most often for other events (5), results of operations (4), officer or director change (3) and shareholder vote results (1). The latest officer or director change was reported on Mar 30, 2026.

3 of the 20 investors tracked here held Incyte at the last quarter end, worth $422.1M combined. It is the largest weight for Renaissance Technologies (0.5% of its portfolio), followed by Bridgewater Associates (0.1%). Added: Bridgewater Associates. Reduced: Renaissance Technologies and National Pension Service (Korea).

Annual results

Fiscal year ends Dec 31 · incorporated in DE

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.